Block, Geoffrey A <br/><br/>
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.  [electronic resource] 

 -  JAMA  01 2017 
 - 146-155 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2016.19456  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Calcimimetic Agents--administration & dosage<br/>Calcium--blood<br/>Double-Blind Method<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Humans<br/>Hyperparathyroidism, Secondary--blood<br/>Infusions, Intravenous--methods<br/>Male<br/>Middle Aged<br/>Parathyroid Hormone--blood<br/>Peptides--administration & dosage<br/>Placebo Effect<br/>Renal Dialysis<br/>Renal Insufficiency, Chronic--complications<br/>Time Factors